Global Perspectives on Brief Cognitive Assessments for Dementia Diagnosis.
Alzheimer’s disease
cultural diversity
dementia
mental status and dementia tests
mild cognitive impairment
Journal
Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863
Informations de publication
Date de publication:
2021
2021
Historique:
pubmed:
15
6
2021
medline:
16
9
2021
entrez:
14
6
2021
Statut:
ppublish
Résumé
Timely diagnosis of dementia is a global healthcare priority, particularly in low to middle income countries where rapid increases in older adult populations are expected. To investigate global perspectives on the role of brief cognitive assessments (BCAs) in dementia diagnosis, strengths and limitations of existing measures, and future directions and needs. This is a qualitative study of 18 dementia experts from different areas of the world. Participants were selected using purposeful sampling based on the following criteria: 1) practicing in countries with projected growth of older adult population of over 100%by 2050; 2) expertise in dementia diagnosis and treatment; 3) involvement in clinical practice and training; and 4) recognition as a national dementia expert based on leadership positions within healthcare system, research, and/or policy work. Participants were individually interviewed in their language of choice over secure videoconference sessions. Interviews were analyzed by a multidisciplinary team using theme identification approach. Four domains with subthemes emerged illustrating participants' perspectives: 1) strengths of BCAs; 2) limitations of BCAs; 3) needs related to the use of BCAs; and 4) characteristics of an ideal BCA. While most experts agreed that BCAs were important and useful for dementia diagnosis, the themes emphasized the need for development and validation of novel measures that are sensitive, psychometrically sound, and culturally appropriate. BCAs are important for guiding diagnosis and care for dementia patients. Findings provide a roadmap for novel BCA development to assist in diagnostic decision making for clinicians serving a rapidly growing and diverse dementia population.
Sections du résumé
BACKGROUND
Timely diagnosis of dementia is a global healthcare priority, particularly in low to middle income countries where rapid increases in older adult populations are expected.
OBJECTIVE
To investigate global perspectives on the role of brief cognitive assessments (BCAs) in dementia diagnosis, strengths and limitations of existing measures, and future directions and needs.
METHODS
This is a qualitative study of 18 dementia experts from different areas of the world. Participants were selected using purposeful sampling based on the following criteria: 1) practicing in countries with projected growth of older adult population of over 100%by 2050; 2) expertise in dementia diagnosis and treatment; 3) involvement in clinical practice and training; and 4) recognition as a national dementia expert based on leadership positions within healthcare system, research, and/or policy work. Participants were individually interviewed in their language of choice over secure videoconference sessions. Interviews were analyzed by a multidisciplinary team using theme identification approach.
RESULTS
Four domains with subthemes emerged illustrating participants' perspectives: 1) strengths of BCAs; 2) limitations of BCAs; 3) needs related to the use of BCAs; and 4) characteristics of an ideal BCA. While most experts agreed that BCAs were important and useful for dementia diagnosis, the themes emphasized the need for development and validation of novel measures that are sensitive, psychometrically sound, and culturally appropriate.
CONCLUSION
BCAs are important for guiding diagnosis and care for dementia patients. Findings provide a roadmap for novel BCA development to assist in diagnostic decision making for clinicians serving a rapidly growing and diverse dementia population.
Identifiants
pubmed: 34120897
pii: JAD201403
doi: 10.3233/JAD-201403
pmc: PMC9450569
mid: NIHMS1832885
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1001-1013Subventions
Organisme : NIA NIH HHS
ID : K01 AG059840
Pays : United States
Organisme : NHLBI NIH HHS
ID : K23 HL148530
Pays : United States
Organisme : NINDS NIH HHS
ID : UG3 NS105557
Pays : United States
Commentaires et corrections
Type : ErratumIn
Références
J Prev Alzheimers Dis. 2021;8(3):267-276
pubmed: 34101783
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
J Alzheimers Dis. 2015;49(3):617-31
pubmed: 26484931
Am J Alzheimers Dis Other Demen. 2015 Feb;30(1):13-28
pubmed: 24526761
Front Psychiatry. 2019 Dec 13;10:878
pubmed: 31920741
Neurology. 1996 Mar;46(3):700-6
pubmed: 8618670
J Alzheimers Dis. 2015;49(4):961-9
pubmed: 26756324
Neurology. 2018 Aug 7;91(6):264-270
pubmed: 29997191
J Int Neuropsychol Soc. 2020 Mar;26(3):331-351
pubmed: 31511111
Clin Neuropsychol. 2016 Nov;30(8):1380-1388
pubmed: 27767896
Alzheimers Dement. 2008 Nov;4(6):428-37
pubmed: 19012868
Neurology. 2015 Sep 8;85(10):910-8
pubmed: 26163433
Alzheimers Res Ther. 2013 Nov 21;5(6):58
pubmed: 24257331
Lancet. 2017 Dec 16;390(10113):2673-2734
pubmed: 28735855
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Clin Neuropsychol. 2018 Jan;32(1):16-41
pubmed: 28590154
Curr Opin Psychiatry. 2015 Mar;28(2):165-72
pubmed: 25602241
Appl Neuropsychol Adult. 2018 Mar-Apr;25(2):174-187
pubmed: 27841690
Res Gerontol Nurs. 2009 Jul;2(3):214-24
pubmed: 20078011
Adm Policy Ment Health. 2015 Sep;42(5):533-44
pubmed: 24193818
Alzheimers Dement. 2017 Apr;13(4):468-492
pubmed: 27702618